Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
SWAV ShockWave Medical
187.830-6.810-3.50%
Close
01/27 16:00 ET
187.8300.0000.00%
Post Mkt Price 01/27 16:17 ET
High
193.670
Open
193.670
Turnover
43.67M
Low
185.592
Pre Close
194.640
Volume
231.03K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Piper Sandler Lowers ShockWave Medical (NASDAQ:SWAV) Price Target to $280.00
ShockWave Medical (NASDAQ:SWAV – Get Rating) had its price target decreased by Piper Sandler from $300.00 to $280.00 in a research report issued to clients and investors on Thursday, The Fly reports
ShockWave Medical (NASDAQ:SWAV) Shares Down 3.7% on Insider Selling
ShockWave Medical, Inc. (NASDAQ:SWAV – Get Rating)'s stock price traded down 3.7% on Friday after an insider sold shares in the company. The company traded as low as $185.59 and last traded at $187.3
Is ShockWave Medical (NASDAQ:SWAV) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Piper Sandler Adjusts ShockWave Medical's Price Target to $280 From $300, Keeps Overweight Rating
11:27 AM EST, 01/26/2023 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
Shockwave Medical Is Maintained at Overweight by Piper Sandler
Shockwave Medical Is Maintained at Overweight by Piper Sandler
Shockwave Medical Price Target Cut to $280.00/Share From $300.00 by Piper Sandler
ShockWave Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/26/2023 46.94% Piper Sandler $300 → $280 Maintains Overweight 01/06/2023 17.55% Morgan Stanley $290 → $
Piper Sandler Maintains Overweight on ShockWave Medical, Lowers Price Target to $280
Piper Sandler analyst Adam Maeder maintains ShockWave Medical (NASDAQ:SWAV) with a Overweight and lowers the price target from $300 to $280.
ShockWave Medical Price Target Lowered to $280 From $300 at Piper Sandler
ShockWave Medical, Inc. (NASDAQ:SWAV) Shares Bought by Raymond James Financial Services Advisors Inc.
Raymond James Financial Services Advisors Inc. grew its position in shares of ShockWave Medical, Inc. (NASDAQ:SWAV – Get Rating) by 39.7% during the third quarter, according to its most recent Form
Company Overview
More
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.
CEO： Mr. Douglas E. Godshall
Market： NASDAQ
Listing Date： 03/07/2019
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet